HC Wainwright & Co. Reiterates Neutral on Assembly Biosciences
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Ed Arce has reiterated a Neutral rating on Assembly Biosciences (NASDAQ:ASMB).

June 13, 2024 | 10:33 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
HC Wainwright & Co. analyst Ed Arce has reiterated a Neutral rating on Assembly Biosciences (NASDAQ:ASMB).
The reiteration of a Neutral rating suggests that the analyst does not see significant upside or downside potential in the short term. This is likely to result in a neutral impact on the stock price.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100